First Review article published from my lab MCB at UofG (together with Gian and Dev Donnelly Centre): Emerging drug development technologies targeting ubiquitination for cancer therapeutics doi.org/10.1016/j.phar…

Emerging drug development technologies targeting ubiquitination for cancer therapeutics reviewed by Sachdev Sidhu #DonnellyCentre & Wei Zhang University of Guelph sciencedirect.com/science/articl…

Our bet is on the Donnelly (current and past members) team

Honoured to take on the role of Associate Vice-President and Vice-Provost, Strategic Initiatives University of Toronto, driving innovation and collaboration across campus. Grateful for my time as Interim Dean and for my wonderful colleagues Leslie Dan Faculty of Pharmacy. Excited about the new phase!

Saying good-bye to the end of an era in the Sidhu lab. Christine Misquitta will be missed but will assuredly go on to accomplish wonderful things in her new role.

Dream come true: back to back publications with Rebecca Shapiro

A great idea to set expectations for everyone involved. Industry already practices this, it might be time for academia to follow suit. sciencemag.org/careers/2019/0…

Interesting and informative podcast from one of our collaborators. stemcellpodcast.com/ep-153-signal-…

TRAC and the Sidhu Lab University of Toronto are working on #SyntheticAntibody treatments against #COVID19 awaiting the green light for #ClinicalTrial. #antivirals #antibodies #innovation torontolife.com/city/reasons-t…

Sidhu lab's team University of Toronto assembled a database of thousands of unique phage-displayed peptides enabeling structural, functional and biological studies of natural protein-protein interactions

Congratulations to Dr. Sachdev Sidhu for his election as a fellow of the National Academy of Inventors

Congratulations to the Sidhu lab's team and Reflexion Pharmaceuticals on a collaborative research article featured on the cover page of ACS Chemical biology! #antibodies #innovation #lifesciences #CancerResearch pubs.acs.org/doi/abs/10.102…

Congratulations to the Sidhu lab’s team on developing a novel in silico method for discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing! #antibodies nature.com/articles/s4200…

Congratulations to our collaborator Stephane Angers and the team on a groundbreaking publication! A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy | EMBO Molecular Medicine embopress.org/doi/full/10.15…

Antibodies developed University of Toronto in the #Toronto Recombinant Antibody Centre TRAC in collab with @WUSTL and University of Pittsburgh helped to validate that #Lrp1 is a #hostreceptor for #RiftValleyFever #Virus #RVFV #hostvirusinteractions #syntheticantibodies sciencedirect.com/science/articl…

International research consortium led by Dr. Dev Sidhu discovered tetravalent antibodies as potential new therapeutics for COVID-19, effective against mutants 👏 #antibodies #COVID19 sciencedirect.com/science/articl…

Congratulations to the Sidhu lab’s team who utilized the power of its ubiquitine variants technology to design new modulators of deubiquitinase activity and provide an alternative means of inhibiting disease-associated ubiquitin specific protease family! sciencedirect.com/science/articl…

(2 of 2) Announcing our 2021 Research Grant Competition Winners! (bottom row, left) Congratulations Drs. Ong Tone Stephan Ong Tone MD PhD Sunnybrook Health Sciences Centre,Thanabalasuriar Ajitha Thanabalasuriar McGill University, Salman University of Manitoba, & Sidhu TRAC University of Toronto! Learn more: bit.ly/3FjkATM

Announcing one of FBC's 2021 Research Grant Competition winners, Dr. Sachdev Sidhu, University of Toronto for his project, Testing a new treatment for age-related macular degeneration (AMD) & diabetic retinopathy (DR). bit.ly/3FjkATM #ResearchGrant #VisionHealth TRAC